SOHM, Inc. Announce its New Product Line
SOHM, Inc. Announce its New Product CBD Full-Spectrum Pain Relief Cream
Chino Hills, CA – December 21, 2020 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today some of the developments with the company and their new product line into the US OTC retail, prescription, contract manufacturing, and white label manufacturing and marketing space.
Mr. Baron Night-CEO announced today that the company has continued with the development and introduction of its first new personal care topical product CBD Pain Relief Cream. This product is made with CBD Full-spectrum distillate with Aloe Vera. It has a very fast-acting absorptions rate and helping reduce the pain.
The company also plans to introduce its second product in near future in the same product line as OTC Pain Relief Cream with CBD added for more effectiveness. This is in continuation of its strategy to the introduction of new products into its product line while maintaining consistency with the company’s outlook and strategic plan. All manufacturing is in the USA, Mr. Night CEO added.
After a thorough review, CEO Mr. Night added that new opportunity to cannabidiol and its derivative consumer healthcare market, the company decided to introduce its new product line which has the potential to grow almost 123 billion by the year 2027 and annually at a CAGR of 25.6% over the forecast period. We intend to develop and introduce more new products into similar markets based on product demand.
The product is going to be available for retail buying on our online store at https://store.sohm.com within 3 weeks while working to make it available at various physical stores.
SOHM is committed to introducing some more additional new products in-line with its “Globalè Prospèro Vision 2024” in the coming weeks/months with its focus on B2C and B2B segments. Mr. Night stated.
The company is still working and generating revenues with its B2B private label prescription
product customers in conjunction with its Business to Consumer segments.
Mr. Night said with addition to this new product line, the company is highly optimistic about its revenue growth as presented under our “Globalè Prospèro 2024” vision.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as a strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
Safe Harbor Statement:
This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700